Aton Ra Partners Nkarta, Inc. Transaction History

Aton Ra Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$3.37 - $6.3 $7,794 - $14,571	-2,313 Reduced 10.31%	20,111 $71,000
Q4 2022 Feb 02, 2023	SELL	$5.14 - $14.35 $31,168 - $87,018	-6,064 Reduced 21.29%	22,424 $134,000
Q3 2022 Nov 14, 2022	SELL	$12.27 - $18.39 $28,024 - $42,002	-2,284 Reduced 7.42%	28,488 $375,000
Q2 2022 Aug 15, 2022	BUY	$7.77 - $19.44 $239,098 - $598,207	30,772 New	30,772 $379,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.